Quick Search:       Advanced Search
Research progresses of PI3K/Akt signaling pathway in hepatic ischemia-reperfusion injury
    Click here to download the full text
Citation of this paper:.Research progresses of PI3K/Akt signaling pathway in hepatic ischemia-reperfusion injury[J].Chinese Journal of Clinical Medicine,2018,25(1):103-107
Hits: 2272
Download times: 1175
Author NameAffiliation
陈勇1,2, 付贞1,3, 范林1, 熊艳1, 叶啟发1,3*, 秦伟2* 1. 武汉大学中南医院武汉大学肝胆疾病研究院武汉大学 移植医学中心移植医学技术湖北省重点实验室武汉 430071 2. 青海大学附属医院腹部腔镜外科西宁 810001 3. 中南大学湘雅三医院卫生部移植医学工程技术研究中心长沙 410013 
Abstract:Liver ischemia-reperfusion injury is the leading cause of delayed recovery of liver function and dysfunction after operation. Some studies have shown that PI3K/Akt signaling pathway is activated during ischemia and reperfusion, which plays a protective role on the liver by inhibiting or enhancing the expressions of downstream target proteins. Therefore, PI3K/Akt signaling has become an important target pathway for preventing and improving hepatic ischemia-reperfusion injury. This review summarized the research progresses of PI3K/Akt signaling pathway in hepatic ischemia-reperfusion injury.
keywords:PI3K/Akt  ischemia-reperfusion injury  inflammatory response  oxidative stress  apoptosis  autophagy
HTML  View Full Text  View/Add Comment  Download reader